Groupe Hospitalier de l' Institut Catholique, Lille Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2006
NCT00642980
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Groupement des Hôpitaux de l'Institut Catholique de Lille | Groupement des Hôpitaux de l'Institut Catholique de Lille (GHICL) - France

Active Ingredients

Drugs in Phase 4 Trials (1)

clindamycin (cleocin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Premature Birth (Phase 4)

Vaginal Diseases (Phase 4)

Vaginosis, Bacterial (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1